• Login
    View Item 
    •   DSpace Home
    • Facultad de Medicina, Enfermería, Nutrición y Tecnología Médica
    • IBBA - Instituto Boliviano de Biología de la Altura
    • Producción científica
    • View Item
    •   DSpace Home
    • Facultad de Medicina, Enfermería, Nutrición y Tecnología Médica
    • IBBA - Instituto Boliviano de Biología de la Altura
    • Producción científica
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    Hemoglobin mass and blood volume in patients with altitude-related polycythemia

    Thumbnail
    View/Open
    SchmidtHemoglobin.pdf (1.515Mb)
    Date
    2022
    Author
    Schmidt, Walter FJ
    Wachsmuth, Nadine
    Jiménez, Jesús
    Soria, Rudy
    Metadata
    Show full item record
    Abstract
    Patients with chronic mountain sickness (CMS) have a high hemoglobin concentration [Hb] due to increased hemoglobin mass (Hbmass) and possibly reduced plasma volume (PV). The values of Hbmass, PV and blood volume (BV) have been described differently, and the relationships between [Hb] and Hbmass or PV are poorly understood. This study obtained representative Hbmass, PV and BV data from healthy, high-altitude residents and CMS patients and quantified the dependency of [Hb] on Hbmass and PV. Methods: Eighty-seven subjects born at high altitude (∼3,900 m) were enrolled. Thirty-four had CMS (CMS), 11 had polycythemia without CMS (intermediate, IM), 20 were healthy highlanders (HH), and 22 living near sea level (SL, 420 m) served as the sea level (SL) control group. Hbmass, PV and BV were determined using a CO-rebreathing method modified for assessing polycythemia patients. Furthermore, [Hb], hematocrit (Hct), plasma erythropoietin concentration [EPO] and blood gas and acid–base status were determined. Results: In the HH group, Hbmass was 27% higher (940 ± 105 g) than in the SL group (740 ± 112 g) and 72% (1,617 ± 265 g) lower than in the CMS group. The PV in the HH group was similar to that in the SL group (−6%) and 15% higher than that in the CMS group (p < 0.001). In the HH group, the BV (5,936 ± 673 ml) did not differ from that in the SL group and was 28% lower than in the CMS group (7,606 ± 1075 ml, p < 0.001). Log [EPO] was slightly increased in the CMS group relative to the HH group (p < 0.01). All values in the IM group were between those in the HH and CMS groups. Hbmass and BV were positively correlated, and PV was negatively correlated with peripheral O2 saturation. Increased Hbmass and decreased PV contributed approximately 65 and 35%, respectively, to the difference in [Hb] between the HH (17.1 ± 0.8 g/dl) and CMS (22.1 ± 1.0 g/dl) groups. Conclusions: In CMS patients, the decrease in PV only partially compensated for the substantial increase in Hbmass, but it did not prevent an increase in BV; the decrease in PV contributed to an excessively high [Hb].
    URI
    http://repositorio.umsa.bo/xmlui/handle/123456789/28911
    Collections
    • Producción científica

    suiumsa
    Universidad Mayor de San Andrés
    Ciudad de La Paz - Estado Plurinacional de Bolivia.
    copyleft © 2024 
    Contact Us
    @dtic
     

     


    suiumsa
    Universidad Mayor de San Andrés
    Ciudad de La Paz - Estado Plurinacional de Bolivia.
    copyleft © 2024 
    Contact Us
    @dtic